Literature DB >> 21761271

A rule to identify patients who require magnetic resonance imaging after intracerebral hemorrhage.

Hooman Kamel1, Babak B Navi, J Claude Hemphill.   

Abstract

BACKGROUND: A study performed in Hong Kong of catheter angiography after ICH found a high rate of structural lesions in patients 45 years of age or younger, without a history of hypertension, or with lobar hemorrhage. We hypothesized that a clinical decision rule based on these Hong Kong criteria would reliably identify patients who require MRI after ICH.
METHODS: We identified all patients admitted with ICH to our medical center during a 5-year period who underwent brain MRI. Patients were excluded if the history revealed an obvious cause of ICH. Two study neurologists independently adjudicated whether MRI revealed the cause of ICH. We devised a rule recommending MRI if patients met one or more Hong Kong criteria, and calculated the proportion of patients with diagnostic MRI studies who would have been identified by this rule. We also examined the performance of a modified rule using age ≤ 55 years.
RESULTS: The original Hong Kong rule applied to 102 of the 148 patients in our cohort (69%), and would have recommended MRI in 25 of 27 patients with diagnostic MRI studies (93%, 95% CI 76-99%). The modified rule applied to 110 patients (74%), and would have recommended MRI in all 27 patients with diagnostic MRI studies (100%, 95% CI 91-100%).
CONCLUSIONS: A rule based on simple clinical criteria may be useful for stratifying the yield of MRI after ICH. If validated in further studies, such a rule could reduce the number of unnecessary MRI studies after ICH, leading to more cost-effective care.

Entities:  

Mesh:

Year:  2013        PMID: 21761271     DOI: 10.1007/s12028-011-9607-7

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  13 in total

1.  Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.

Authors:  J P Broderick; H P Adams; W Barsan; W Feinberg; E Feldmann; J Grotta; C Kase; D Krieger; M Mayberg; B Tilley; J M Zabramski; M Zuccarello
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

Review 2.  Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature.

Authors:  X L Zhu; M S Chan; W S Poon
Journal:  Stroke       Date:  1997-07       Impact factor: 7.914

3.  Utility of magnetic resonance imaging in acute intracerebral hemorrhage.

Authors:  D A Dylewski; A M Demchuk; L B Morgenstern
Journal:  J Neuroimaging       Date:  2000-04       Impact factor: 2.486

4.  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1997-05-31       Impact factor: 79.321

5.  External validation of the ICH score.

Authors:  Jennifer L Clarke; S Claiborne Johnston; Mary Farrant; Richard Bernstein; David Tong; J Claude Hemphill
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

7.  Radiological investigation of spontaneous intracerebral hemorrhage: systematic review and trinational survey.

Authors:  Charlotte Cordonnier; Catharina J M Klijn; Janneke van Beijnum; Rustam Al-Shahi Salman
Journal:  Stroke       Date:  2010-02-18       Impact factor: 7.914

8.  Declining US stroke hospitalization since 1997: National Hospital Discharge Survey, 1988-2004.

Authors:  Jing Fang; Michael H Alderman; Nora L Keenan; Janet B Croft
Journal:  Neuroepidemiology       Date:  2008-01-07       Impact factor: 3.282

9.  Lobar intracerebral hemorrhage. A clinical, radiographic, and pathological study of 29 consecutive operated cases with negative angiography.

Authors:  S Wakai; N Kumakura; M Nagai
Journal:  J Neurosurg       Date:  1992-02       Impact factor: 5.115

10.  Cerebral amyloid angiopathy.

Authors:  G R Cosgrove; R Leblanc; K Meagher-Villemure; R Ethier
Journal:  Neurology       Date:  1985-05       Impact factor: 9.910

View more
  4 in total

Review 1.  Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.

Authors:  Cristhiam M Rojas-Hernandez; Thein Hlaing Oo; Herney Andrés García-Perdomo
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

Review 2.  A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage.

Authors:  Humaira Sadaf; Virendra R Desai; Vivek Misra; Eugene Golanov; Muralidhar L Hegde; Sonia Villapol; Christof Karmonik; Angelique Regnier-Golanov; Dimitri Sayenko; Philip J Horner; Robert Krencik; Yi Lan Weng; Farhaan S Vahidy; Gavin W Britz
Journal:  Ann Clin Transl Neurol       Date:  2021-10-14       Impact factor: 4.511

Review 3.  Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhage.

Authors:  Colin B Josephson; Philip M White; Ashma Krishan; Rustam Al-Shahi Salman
Journal:  Cochrane Database Syst Rev       Date:  2014-09-01

4.  DELAYED DIAGNOSIS OF AVM PRESENTING WITH STROKE AND SEIZURES IN A YOUNG NIGERIAN: A CASE REPORT.

Authors:  A I Makanjuola; P Bolaji; C Onyejelam; G I Ogbole; R O Akinyemi
Journal:  Ann Ib Postgrad Med       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.